AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2018
Jan 4, 2018
10196_dirs_2018-01-04_d025b93e-0545-4b7a-81f2-b088aae92d83.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2018-01-03
Reporting Person: Cox Russell J. (Director, Chief Executive Officer)
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 28
Board/Management Information
2026
Apr 28
Share Issue/Capital Change
2026
Apr 23